Cargando…

Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos

BACKGROUND: Although the anti-diabetic activity of Aegle marmelos (AM) is known, however, its anti-glycation activity is not reported yet. In this study, we have investigated its anti-glycation activity under in vitro and in vivo conditions and determined possible mechanism(s) in streptozotocin-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafizur, Rahman M., Momin, Shahrukh, Fatima, Noor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399853/
https://www.ncbi.nlm.nih.gov/pubmed/28431540
http://dx.doi.org/10.1186/s12906-017-1743-y
_version_ 1783230720928382976
author Hafizur, Rahman M.
Momin, Shahrukh
Fatima, Noor
author_facet Hafizur, Rahman M.
Momin, Shahrukh
Fatima, Noor
author_sort Hafizur, Rahman M.
collection PubMed
description BACKGROUND: Although the anti-diabetic activity of Aegle marmelos (AM) is known, however, its anti-glycation activity is not reported yet. In this study, we have investigated its anti-glycation activity under in vitro and in vivo conditions and determined possible mechanism(s) in streptozotocin-induced diabetic rats. METHODS: Effective dose of AM (400 mg/kg) was administrated orally to diabetic rats for 42 days. Thereafter, blood glucose, serum insulin, HbA1c, antioxidant status, and advanced glycation end-products (AGEs) were measured. AGEs and its receptor (RAGE) in kidney were analyzed by immunohistochemistry and immunoblotting. Additionally, pancreatic sections were co-stained for insulin and glucagon and images were acquired using NIKON TE2000E fluorescence microscopy. RESULTS: Oral administration of AM extract resulted in a significant increase in serum insulin by better functioning of β-cell and preserving pancreatic β-cell integrity in diabetic rats. Treatment of AM extract significantly (p = 0.000) prevented the formation of HbA1c in the diabetic rats (8.20 ± 0.18% vs. 11.92 ± 0.59%). The circulatory AGEs level found in diabetic rat was significantly (p = 0.002) attenuated by AM treatment (0.66 ± 0.05 mg/ml vs. 1.18 ± 0.19 mg/ml). AM treatment also reduced AGEs accumulation around Bowman’s capsule and in tubular basement membrane around arteries in diabetic rat kidney. The accumulation of RAGE was very similar to that of AGEs in diabetic rats and RAGE accumulation was also prevented by AM treatment. The extract showed potent antioxidant activity both under in vitro and in vivo systems. Eugenol, one of the active constituent of AM fruit extract, showed acute blood glucose-lowering activity in diabetic rats and enhanced glucose-stimulated insulin secretion from mice islets. CONCLUSION: AM extract prevents AGEs formation by modulating β-cell function, and eugenol may play important role in preventing complications of diabetes in this rat model.
format Online
Article
Text
id pubmed-5399853
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53998532017-04-24 Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos Hafizur, Rahman M. Momin, Shahrukh Fatima, Noor BMC Complement Altern Med Research Article BACKGROUND: Although the anti-diabetic activity of Aegle marmelos (AM) is known, however, its anti-glycation activity is not reported yet. In this study, we have investigated its anti-glycation activity under in vitro and in vivo conditions and determined possible mechanism(s) in streptozotocin-induced diabetic rats. METHODS: Effective dose of AM (400 mg/kg) was administrated orally to diabetic rats for 42 days. Thereafter, blood glucose, serum insulin, HbA1c, antioxidant status, and advanced glycation end-products (AGEs) were measured. AGEs and its receptor (RAGE) in kidney were analyzed by immunohistochemistry and immunoblotting. Additionally, pancreatic sections were co-stained for insulin and glucagon and images were acquired using NIKON TE2000E fluorescence microscopy. RESULTS: Oral administration of AM extract resulted in a significant increase in serum insulin by better functioning of β-cell and preserving pancreatic β-cell integrity in diabetic rats. Treatment of AM extract significantly (p = 0.000) prevented the formation of HbA1c in the diabetic rats (8.20 ± 0.18% vs. 11.92 ± 0.59%). The circulatory AGEs level found in diabetic rat was significantly (p = 0.002) attenuated by AM treatment (0.66 ± 0.05 mg/ml vs. 1.18 ± 0.19 mg/ml). AM treatment also reduced AGEs accumulation around Bowman’s capsule and in tubular basement membrane around arteries in diabetic rat kidney. The accumulation of RAGE was very similar to that of AGEs in diabetic rats and RAGE accumulation was also prevented by AM treatment. The extract showed potent antioxidant activity both under in vitro and in vivo systems. Eugenol, one of the active constituent of AM fruit extract, showed acute blood glucose-lowering activity in diabetic rats and enhanced glucose-stimulated insulin secretion from mice islets. CONCLUSION: AM extract prevents AGEs formation by modulating β-cell function, and eugenol may play important role in preventing complications of diabetes in this rat model. BioMed Central 2017-04-21 /pmc/articles/PMC5399853/ /pubmed/28431540 http://dx.doi.org/10.1186/s12906-017-1743-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hafizur, Rahman M.
Momin, Shahrukh
Fatima, Noor
Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title_full Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title_fullStr Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title_full_unstemmed Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title_short Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos
title_sort prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by aegle marmelos
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399853/
https://www.ncbi.nlm.nih.gov/pubmed/28431540
http://dx.doi.org/10.1186/s12906-017-1743-y
work_keys_str_mv AT hafizurrahmanm preventionofadvancedglycationendproductsformationindiabeticratsthroughbetacellmodulationbyaeglemarmelos
AT mominshahrukh preventionofadvancedglycationendproductsformationindiabeticratsthroughbetacellmodulationbyaeglemarmelos
AT fatimanoor preventionofadvancedglycationendproductsformationindiabeticratsthroughbetacellmodulationbyaeglemarmelos